The latest science and technology news from the U.S. Virgin Islands

Provided by AGP

Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on March 6, 2026

Odysight.ai Partners with XP Services for First US Flight Testing of its AI-Predictive Maintenance System on UH-60 Helicopter
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
C.M. Advises VisionWave of Joint Venture Initiative in India with Major Industrial Manufacturing Group
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Artelo Biosciences Announces Reverse Stock Split
Signing Day Sports Special Stockholder Meeting to Consider and Vote on Proposed Business Combination with BlockchAIn Digital Infrastructure to Be Held March 13, 2026
EagleNXT Announces Strategic Investment in Leading Israeli Precision Loitering Munition Innovator
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
TSplus Releases Advanced Security v7.5 with Updated Ransomware Protection Driver
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Verano to Report Fourth Quarter and 2025 Full Year Financial Results on March 12th, 2026
AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update
Nano Labs Launches iPollo ClawPC A1 Mini, a Dedicated Hardware Solution for the OpenClaw AI Agent Ecosystem
Tangram Therapeutics gibt Dosierung des ersten Studienteilnehmers in der Phase-I/II-Studie RESTORE-MASH zu TGM-312 bekannt, einem in der Entwicklungsphase befindlichen RNAi-Therapeutikum
Tangram Therapeutics annonce l’administration de la première dose à un participant dans le cadre de l’essai RESTORE-MASH de phase I/II portant sur le TGM-312, un nouveau médicament expérimental à base d’ARNi

Share us

on your social networks:

Sign up for:

Tech Reporter Virgin Islands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.